On ECHEMI
Home > Drugs > Lymphocytic leukemia
Lymphocytic leukemia
There are two types of lymphocytic leukemia, one is acute lymphocytic leukemia and the other is chronic lymphocytic leukemia. Acute lymphocytic leukemia is a progressive malignant disease characterized by a large number of immature white blood cells similar to lymphoblasts. These cells can be found in the blood, bone marrow, lymph nodes, spleen and other organs. Chronic lymphocytic leukemia, referred to as CLL, is a malignant proliferative disease of lymphocytes in certain immune-deficient lymphocytes in the lymphocyte system with a slow onset. This disease is rare in my country, accounting for only 3.4% of leukemia, and is more common in Caucasians in Europe and America, accounting for 25-30%. The age of onset is mostly over 50 years old, and it is rare for those under 30 years old. There are more men than women. The main manifestations are systemic lymphadenopathy, splenomegaly, anemia and abnormal increase in lymphocytes in peripheral blood.
Related Drugs
Thioguanine Tablets
Indication: 1. The induction remission phase and continued treatment phase of acute lymphocytic leukemia and acute non-lymphocytic leukemia. 2. The chronic phase and blast phase of chronic myeloid leukemia.
Thioguanine Tablets
Indication: 1. The induction remission phase and continued treatment phase of acute lymphocytic leukemia and acute non-lymphocytic leukemia. 2. The chronic phase and blast phase of chronic myeloid leukemia.
Thioguanine Tablets
Indication: 1. The induction remission period and continuing treatment period of acute lymphocytic leukemia and acute non-lymphocytic leukemia; 2. The chronic phase and blast crisis phase of chronic myeloid leukemia.
Manufacturer:

Beijing Jialin Pharmaceutical Co., Ltd.

Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:

Shanghai Sine Pharmaceutical Laboratories Co., Ltd.

Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:

Zhejiang Zhebei Pharmaceutical Co., Ltd.

Mercaptopurine Tablets
Indication: It is suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia, acute non-lymphocytic leukemia, and the blast crisis of chronic myeloid leukemia.
Manufacturer:

Shaanxi Traditional Chinese Medicine Research Institute Hantang Pharmaceutical C O., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.